Methods for tailoring the immune response to an antigen or immunogen
The invention relates to methods and reagents for immunizing animals to elicit specific cellular and humoral immune-responses against specific antigens, such as viral antigens, including HBsAg antigen. The invention provides methods of using specifically prepared immunogen in fresh or lyophilized liposome, proper routes of administration of the immunogen, proper doses of the immunogen, and specific combinations of heterologous immunization including DNA priming in one administration route followed by liposome-mediated protein antigen boost in a different route to tailor the immune responses in respects of enhancing cell mediated immune response, cytokine secretion, humoral immune response, immune protection and selective skewing of T helper responses to be Th1, Th2, or a mixed or balanced Th response.
1 . A method for eliciting a desired immune response in an animal, comprising administering to the animal:
a) a priming preparation comprising a nucleic acid encoding an antigen; and
b) a boosting preparation comprising the antigen and liposomes, thereby eliciting the desired immune response in the animal.
2 . The method of claim 1 , wherein the desired immune response is against a pathogen and the antigen is a pathogen-specific antigen.
3 . The method of claim 2 , wherein the priming preparation is administered by a route selected from: subcutaneously, intramuscularly, intradermally and mucosally, and the boosting preparation is administered by a route selected from: subcutaneously, intramuscularly, intradermally and mucosally.
4 . The method of claim 3 , wherein the boosting preparation is administered intranasally to the animal.
5 . The method of claim 4 , wherein the boosting preparation comprises a pathogen-specific protein antigen encapsulated in liposomes.
6 . The method of claim 5 , wherein the liposomes in the boosting preparation average about 0.5-5 μm in size.
7 . The method of claim 6 , wherein the immune response confers immunity against the pathogen.
8 . The method of claim any one of claims 2 - 7 , wherein the pathogen is a virus.
9 . The method of claim 8 , wherein the virus is HBV, and the pathogen-specific antigen is HBsAg.
10 . The method of claim 9 , wherein the animal is human.
11 . A method for eliciting a desired immune response biased towards a Th1 response in a host animal, comprising:
a) administering intramuscularly to the animal a priming preparation comprising a nucleic acid encoding an antigen; and
b) subsequently administering to the animal a boosting preparation comprising the antigen and liposomes, thereby eliciting the desired immune response biased towards a Th1 response in the animal.
12 . The method of claim 11 , wherein the desired immune response biased towards a Th1 response is against a pathogen and the antigen is a pathogen-specific antigen.
13 . The method of claim 12 , wherein the boosting preparation is administered intranasally to the animal.
14 . The method of claim 13 , wherein the boosting preparation comprises a pathogen-specific protein antigen encapsulated in liposomes.
15 . The method of claim 14 , wherein the liposomes in the boosting preparation average about 0.5-5 μm in size.
16 . The method of claim 15 , wherein the immune response confers immunity to the pathogen.
17 . The method of any one of claims 1 - 16 , wherein the pathogen is a virus.
18 . The method of claim 17 , wherein the virus is HBV, and the pathogen-specific antigen is HBsAg.
19 . The method of claim 18 , wherein the animal is a human.
20 . A kit for eliciting an immune response in a host animal, comprising:
a) a first immunizing component comprising a nucleic acid encoding an antigen;
b) a second immunizing component comprising the antigen and liposomes; and
c) an instruction for an user to administer to the animal the first immunizing component followed with administering the second immunizing component to elicit an immune response in the animal.
21 . The kit of claim 20 , wherein the desired immune response is against a pathogen and the antigen is a pathogen-specific antigen.
22 . The kit of claim 21 , wherein the administration of the first immunizing component may be by any route selected from: subcutaneously, intramuscularly, intradermally and mucosally, and the administration of the second immunizing component may be by any route selected from: subcutaneously, intramuscularly, intradermally and mucosally.
23 . The kit of claim 22 , wherein the second immunizing component is administered intranasally to the animal.
24 . The kit of claim 23 , wherein the second immunizing component comprises a pathogen-specific protein antigen encapsulated in liposomes.
25 . The kit of claim 24 , wherein the liposomes in the boosting preparation average about 0.5-5 μm in size.
26 . The kit of any one of claims 20 - 25 , wherein the pathogen is a virus.
27 . The kit of claim 26 , wherein the virus is HBV, and the pathogen-specific antigen is HBsAg.
28 . The kit of claim 27 , wherein the animal is a human.